Company Filing History:
Years Active: 2005-2011
Title: Dietmar Weilguny: Innovator in Recombinant Protein Technology
Introduction
Dietmar Weilguny is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of methods for manufacturing recombinant proteins. With a total of 2 patents, his work has implications for therapeutic applications in medicine.
Latest Patents
Weilguny's latest patents include a method for manufacturing a recombinant polyclonal protein. This invention relates to a method for creating a recombinant polyclonal antibody composition. The process involves obtaining a collection of cells that are transfected with various nucleic acid sequences, allowing each cell to express a distinct member of a polyclonal protein. The cells are cultured under conditions that promote the expression of the polyclonal protein, which can be harvested from the cells or the culture supernatant. This method is particularly suitable for producing recombinant polyclonal antibodies for therapeutic uses.
Another significant patent by Weilguny is focused on making recombinant proteins. This invention provides nucleic acid molecules and vector constructs that include scaffold/matrix attachment regions. These regions are essential for the industrial production of recombinant proteins and polypeptides, enhancing the efficiency of the production process.
Career Highlights
Throughout his career, Dietmar Weilguny has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Symphogen A/S and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in recombinant protein technology.
Collaborations
Weilguny has collaborated with several professionals in his field, including Lars Soegaard Nielsen and Anne Bondgaard Tolstrup. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in biotechnology.
Conclusion
Dietmar Weilguny stands out as an influential inventor in the realm of recombinant protein technology. His patents and career achievements reflect his commitment to advancing therapeutic applications in biotechnology. His work continues to impact the industry positively.